IP Library Granted Patent US 7,037,662
Granted Patent B1
US 7,037,662 · App. 09/104,340 · Granted May 2, 2006

Receptor-ligand system and assay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,037,662
App. No.
09/104,340
Granted
May 2, 2006
Kind
B1
Abstract

An Eph family RTK (receptor tyrosine kinase) ligand-binding domain as well as a method of identifying Eph family RTK agonists or antagonist. The ligand-binding domain is suitably encoded by exon III of a gone encoding the RTK of the Eph family and may additionally include an amino acid sequence encoded by exon II of the gene. The ligand-binding domain may be a polypeptide having amino acids 57-271 of the sequence shown in FIG. 1.

Claims (14)

1. An isolated polypeptide which binds a ligand selected from the group consisting of LERK3, LERK4, LERK5 and LERK7, wherein said isolated polypeptide consists of the amino acid sequence set forth in SEQ ID NO:4.

2. The isolated polypeptide of claim 1 , wherein said polypeptide has at least one pair of disulfide cysteine residues selected from the group consisting of:

(i) Cys 71 -Cys 189 ; and

(ii) Cys 259 -Cys 270 ,

wherein said cysteine residues are identified in SEQ ID NO:4.

3. An isolated polypeptide which binds a LERK, said polypeptide consisting of the amino acid sequence of SEQ ID NO:4.

4. The polypeptide of claim 3 , wherein the LERK is LERK7.

5. The isolated polypeptide of claim 1 which is a recombinant polypeptide produced by a host cell.

6. A method of identifying a molecule which binds the polypeptide of claim 1 , which method includes the steps of:

(i) combining a sample suspected of containing said molecule with the polypeptide of claim 1 ; and

(ii) determining if said molecule is present in said sample by measuring the binding of the molecule to said polypeptide; wherein binding identifies said molecule.

7. A method of identifying a molecule which competes with binding of a ligand to the polypeptide of claim 1 , which method includes the steps of:

(i) combining a sample suspected of containing said molecule, a ligand and at the polypeptide of claim 1 ; and

(ii) determining if the molecule is present in the sample by measuring the competitive binding of the molecule and the ligand with said polypeptide; wherein a molecule that competes with ligand for binding to said polypeptide identifies said molecule.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045788/0148 →
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →
SECURITY INTEREST Recorded Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
SECURITY INTEREST Recorded May 23, 2016
From: KALOBIOS PHARMACEUTICALS, INC.
To: BLACK HORSE CAPITAL, LP
Reel/Frame 038788/0266 →